Attracting over 150 experts from Asia, Europe and US, this 2-day event will highlight cutting edge research, commercialization, and business case studies through presentations and a panel discussion, a virtual exhibition filled with solution providers showcasing their products, and ample networking opportunities promoting interactions and business reach.
Labskin is delighted to announce the expansion of the laboratories at the Labskin HQ in York Biotech Campus, York, UK. New Health and Safety procedures are to be implemented in the coming months, which will enable Labskin to have 2 Containment Level 3 (CL3) labs along with our existing laboratory space.
Skin Trust Club allows users to access genome sequencing to understand the unique characteristics of their skin and identify skincare products and routines that suit their unique skin microbiome, delivered via an app.
Advances in microbiology and clinical testing have accelerated the demand for hair products and treatments that target common scalp ailments, leading to the explosion of scientific research in this fascinating subject.
UNE INTRODUCTION AU MICROBIOME DE LA PEAU Le microbiome
Post — 2 Min Read Join Labskin This January
This week sees the Labskin team attending and presenting at the Microbiome Movement: Skin Health & Dermatology USA virtual conference.
Next Monday and Tuesday will see the team from Labskin attending the 7th Microbiome & Probiotic R&D and Business Forum. Due to Covid-19 travel restrictions this event will be hosted on a virtual platform.
Two exciting opportunities have arisen within the Liverpool School of Tropical Medicine to work with the SARS-CoV-2 virus in high containment level laboratories with Labskin, Unilever, University of Liverpool and Genoa.
Labskin has built a remote clinical trial platform that allows trials to happen ethically and efficiently with protocols being followed and distantly controlled; where all data collected is stored according to the strictest of GDPR guidelines; and critically, swabbing can be done under supervision in the trialists’ own home so no in-person contact is needed.
